What You Should Know:
- Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry's most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures.
- The company uses proprietary AI models trained on matched multi-omic samples and clinical outcomes to predict how specific patient populations will respond to new therapies. This "response-first" approach aims to drastically de-risk drug development by identifying responders
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Accenture Invests in Ryght AI to Accelerate Clinical Trials with Agentic AI and Digital Twins
What You Should Know:
- Accenture has made a strategic investment in Ryght AI through its venture capital arm, aiming to modernize the sluggish clinical trial process. Ryght AI utilizes "agentic AI" and its proprietary AI Site Twin platform to create dynamic digital replicas of research sites, allowing pharmaceutical companies to optimize site selection and patient enrollment.
- The strategic collaboration seeks to remove the manual bottlenecks that delay life-saving therapies,
Read More
The Future of Pharma Marketing: How AI and Real-World Data Are Redefining Personalization
Consumers are increasingly learning about potential drug therapies from advertising across the media channels they use regularly – whether it be broadcast or streaming TV, social media, display ads, or streaming radio. One survey found that 63% of patients learned about new treatments through pharmaceutical ads, but capturing and retaining consumer attention continues to be an uphill battle for pharmaceutical marketers, with many consumers experiencing advertising saturation and fatigue. Life
Read More
AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement
What You Should Know:
- Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement globally, fostering stronger relationships with healthcare professionals (HCPs) through data-driven, AI-powered engagement.
- This work will support AstraZeneca’s commitment to push the boundaries of science to
Read More
Circulate Health Secures Strategic Investment from Scrum Ventures to Scale TPE and Microplastics Removal Technology
What You Should Know:
- Circulate Health, a pioneer in Therapeutic Plasma Exchange (TPE) technologies, has secured a seven-figure strategic investment from Scrum Ventures.
- The funding will accelerate the company's growth as it works to position TPE as a scalable, patient-centered solution for longevity care. Circulate's platform leverages TPE to remove microplastics, environmental toxins, and inflammatory markers from the bloodstream, addressing the growing consumer demand
Read More
Transient Warming Events (TWEs): The Silent Threat to Cell and Gene Therapy Integrity
Cell and gene therapies (CGTs) are reshaping medicine. Hundreds of clinical trials are underway worldwide, and the first wave of commercial therapies is already changing the outlook for patients with rare diseases and cancers. Yet as the industry races toward commercialization, a fundamental challenge is threatening to slow progress: preserving the integrity of living cells from the lab to the patient.
One of the most underappreciated risks in this journey are transient warming events (TWE)
Read More
MRO Acquires Clinetic to Accelerate Clinical Trial Patient Recruitment with AI-Driven Data
What You Should Know:
- MRO has acquired Clinetic, a recruitment management platform, to enhance its smarter data commitment. Financial details of the acquisition were not disclosed.
- The acquisition integrates Clinetic’s AI-driven software, which leverages real-time EHR data to identify, screen, and enroll clinical trial patients faster and with greater precision.
MRO Strengthens "Smarter Data" Focus with Clinetic Acquisition
MRO, a company committed to being the single
Read More
Function Launches Medical Intelligence Lab to Decode Longevity with AI and 100+ Biomarkers
What You Should Know:
- Function has created a new category in preventive health—one that shifts how people think about longevity, early detection, and everyday decision-making. The company’s mission is simple but ambitious: empower people to live 100 healthy years. It began by redefining routine testing through its bi-annual, 100+ biomarker lab panel, giving individuals an expansive, longitudinal view of their changing biology.
- The acquisition of Ezra accelerated
Read More
Pharma × AI: The End of Pilots and the Rise of Captive AI Boutiques
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory bench? The answer is arriving faster than many realize.
For years, the relationship between artificial intelligence (AI) startups and big pharma followed a familiar script: a splashy press release, a limited pilot, and then silence after millions were spent in R&D. AI companies gained validation; pharma
Read More
From Chatbots to Agents: How GPT-5 is Reshaping Healthcare and Pharma
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of years running specific pilots involving artificial intelligence (AI). Learnings from these forays have formed a basis for AI readiness and a guide for industry to weave generative AI into enterprise strategies. Even regulators have been experimenting with AI to offset staff shortages and
Read More
